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The literature suggests that there is a geographical, sociodemographic 
and temporal variation in histological patterns of renal disease, but 
data from African countries are fairly limited.[1-3] In South Africa 
(SA), chronic kidney disease (CKD) more than doubled from 1990 
to 2010,[4] with the increase mainly attributed to hypertension and 
glomerular diseases.[5,6]
Chris Hani Baragwanath Academic Hospital (CHBAH) serves a 
predominantly black population of >3.6 million people from Soweto 
(an urban ‘township’ in Gauteng Province, SA) and the surrounding 
areas,[7] and is one of the main referral centres for patients with renal 
disease.
The community served by the hospital has a history of racial 
segregation, poverty and social inequalities.[8] No recent long-term 
data for the renal patient population of CHBAH have been published.
Objectives
To contribute to the knowledge regarding patterns and clinical 
presentation of renal disease at CHBAH and compare it with data 
available for other areas in SA and other countries.
Methods
A retrospective review was conducted of all renal histopathology 
reports from 1 January 1982 to 31 December 2011 for patients biopsied 
in the CHBAH adult renal unit. Renal biopsy remains the most 
precise method for making a definitive diagnosis of renal disease and 
predicting the likely clinical course, and guides further investigations 
and management of patients.[9,10] Our objectives were to describe the 
histopathological patterns of renal disease and to identify clinical 
pathological relationships between patient demographics, clinical 
presentations and histopathological diagnoses. We also compared 
patterns of renal disease between patients who were HIV-positive and 
those who were HIV-negative.
Data gathered included the demographic profile (age, gender, 
ethnicity), results of haematological and urine investigations, indication 
for biopsy and histopathological diagnosis for each patient. Ethics 
approval was obtained from the Human Research Ethics Committee of 
the University of the Witwatersrand (ref. no. M120874).
Native renal biopsy (one in which the patient’s own, as opposed to 
transplanted, kidneys are biopsied) reports of male and female patients 
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Background. Data on renal pathology from sub-Saharan Africa are limited.
Objectives. To report on biopsy-confirmed renal pathology over 30 years in Soweto, South Africa (SA).
Methods. Retrospective analysis was conducted of 1 848 adult native renal biopsies performed at Chris Hani Baragwanath Academic 
Hospital between 1 January 1982 and 31 December 2011.
Results. There was an even gender distribution, and 96.4% of patients were of black ethnicity. The mean (standard deviation) age of patients 
was 33.5 (12.6) years. The main clinical indications for renal biopsy were nephrotic syndrome (47.7%), acute kidney injury (19.8%) and 
asymptomatic urine abnormalities (8.1%). Secondary glomerular diseases (SGNs) (49.3%) occurred more frequently than primary glomerular 
diseases (PGNs) (39.7%). SGNs increased during the study period, while PGNs decreased (p<0.001). The most frequent PGNs were focal 
segmental glomerulosclerosis (FSGS) (29.6%), membranous glomerulonephritis (25.7%) and membranoproliferative glomerulonephritis 
(18.1%). Lupus nephritis (LN) (31.0%) was the most frequent SGN, followed by HIV-associated nephropathy (HIVAN) (13.3%) and malignant 
hypertension (12.5%). HIV-positive biopsies constituted 19.7% of all biopsies, and the proportion increased over time. In HIV-positive patients, 
the most common diagnoses were HIVAN (32.7%), HIV immune complex disease (11.8%) and FSGS (11.3%).
Conclusions. This study contributes to our knowledge of renal pathology in SA and shows some data that differ from studies in other 
regions. The increase in SGNs probably reflects the influence of HIV and LN in the study population.
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aged ≥12 years on which the pathologist reviewing the specimen was 
able to make a definitive pathological diagnosis were included in 
the analysis. At CHBAH, patients aged ≥12 years are managed by the 
adult nephrology unit. Biopsy reports on patients aged <12 years, renal 
allograft biopsies and biopsies where the specimen was inadequate for 
histopathological diagnosis were not included.
Biopsy specimens were processed by pathologists of the National 
Health Laboratory Service (NHLS), and prior to 2001 by the 
South African Institute for Medical Research. Light microscopy and 
immunofluorescence were utilised for all specimens and electron 
microscopy for some specimens.
Histopathological diagnoses were classified into four categories, 
adapted from Mesquita et al.:[11] (i) primary glomerular diseases 
(PGNs); (ii) secondary glomerular diseases (SGNs); (iii) tubulo-
interstitial diseases (TIDs); and (iv) miscellaneous/other.
Patients were considered to have a PGN if at the time of biopsy the 
patient had no report of a known systemic disease and had negative 
serology for hepatitis B and C viruses (HBV and HCV), HIV and 
syphilis, a negative antistreptolysin O titre, negative antinuclear 
antibodies and negative anti-neutrophil cytoplasmic antibodies. 
Patients with glomerular disease not classified as a PGN were 
considered to have an SGN.
PGNs were divided into one of nine pathologies using 
a classification adapted from Polito et al.:[12] (i) minimal-change 
disease (MCD); (ii) membranous glomerulopathy (MGN); (iii)  focal 
segmental glomerulosclerosis (FSGS); (iv) IgA nephropathy (IgAN); 
(v) IgM nephropathy; (vi) mesangioproliferative glomerulo nephri-
tis; (vii)  membranoproliferative glomerulonephritis (MPGN); (viii) 
crescentic glomerulonephritis; and (ix) proliferative glomerulo-
nephritis.[12]
SGNs were subdivided according to aetiology into four categories 
adapted from Polito et al.[12] and Okpechi et al.:[13] (i) glomerular 
disease secondary to a systemic disease (SD), including lupus 
nephritis (LN) and other autoimmune disorders such as rheumatoid 
arthritis and mixed connective tissue disorder; (ii) glomerular disease 
secondary to infectious diseases (IDs), including HIV, HBV, HCV, 
syphilis, post-infectious glomerulonephritis (PIGN) and others; 
(iii)  glomerular disease associated with a metabolic disease or 
deposits (MD), including diabetic nephropathy (DN), amyloidosis, 
light-chain deposition disease, glomerular disease with patterned 
or organised deposits – immunotactoid GN and fibrillary GN; and 
(iv) glomerular disease secondary to vascular disease (VD), including 
benign hypertensive nephroangiosclerosis, malignant hypertensive 
nephroangiosclerosis (MHN), thrombotic microangiopathy, pre-
eclampsia or the HELLP syndrome (haemolysis, elevated liver 
enzymes, low platelet count), atheroembolic renal disease, systemic 
sclerosis and pauci-immune crescentic glomerulonephritis.
Diseases classified as TID included interstitial nephritis (IN), acute 
tubular necrosis (ATN), pyelonephritis and interstitial renal disease 
secondary to myeloma.
Miscellaneous diseases included unclassified diseases, end-stage 
kidney disease (ESKD) of unknown aetiology and unclassified 
glomerulonephritis, hereditary diseases including Alport’s nephritis, 
thin basement membrane disease, oxalate nephropathy and Fabry’s 
disease, tumours, and symptoms suggesting renal disease but with 
normal/non-remarkable histological findings.
Clinical indications for biopsy were subdivided as follows: (i) acute 
kidney injury (AKI); (ii) asymptomatic urine abnormalities (AUAs); 
(iii) CKD; (iv) haematuria; (v) hypertension; (vi) nephrotic syndrome 
(NS)/nephrotic-range proteinuria; (vii) nephritic syndrome; (viii) 
nephritic NS; and (ix) unknown.
SPSS 20 statistical software (IBM, USA) was used for statistical 
analysis. Frequency distributions for demographic data (age, sex 
and ethnicity), clinical presentations and histopathological diagnosis 
were calculated and expressed as proportions. Cross-tabulations 
between the variables of interest were performed and the χ2 test 
of independence was used to evaluate the potential statistical 
significance of associations.[14] Where a χ2 value was calculated, a 
p-value <0.05 was considered significant.
To identify potential changes in renal disease patterns over a 
meaningful time frame and to allow comparison with data from 
similar studies, the 30-year period for which biopsy results were 
available was divided into three 10-year periods, namely 1 January 
1982 - 31 December 1991, 1 January 1992 - 31 December 2001, and 
1 January 2002 - 31 December 2011.
Results
A total of 1 848 histopathology reports were included for analysis. 
A  total of 570 biopsies were performed between 1 January 1982 and 
31  December 1991, 377 were performed between 1 January 1992 
and 31 December 2001, and 901 were performed between 1 January 
2002 and 31 December 2011. With regard to gender distribution, the 
proportions of females (50.2%, n=928) and males (49.8%, n=920) in the 
sample were almost equal, and the mean (standard deviation) age was 
33.5 (12.6) years. The majority of patients were black (96.4%, n=1 782). 
The frequencies of other ethnic groups were relatively low, with 1.6% 
coloured patients (n=29), 1.4% white (n=26) and 0.6% Indian (n=11).
In total, 19.7% (n=364) of patients were HIV-positive, 4.5% (n=83) 
were HBV-positive and 1.5% (n=28) were HCV-positive. Between 
1982 and 1991, only one patient was reported to be HIV-positive; this 
increased to 5.8% between 1992 and 2001, and 37.8% between 2002 
and 2011. Of the HIV-positive patients, 17 (4.7%) were co-infected 
with HCV and 32 (8.8%) with HBV. Young adults aged between 20 
and 39 years accounted for 64.0% of HIV-positive patients.
The most frequent indications for renal biopsy were NS/nephrotic-
range proteinuria (47.7%), AKI (19.8%) and AUAs (8.1%). The 
majority of HIV-positive patients were biopsied for NS/nephrotic-
range proteinuria (39.3%), AKI (38.5%) and CKD (8.2%). The 
frequency of AKI as an indication for biopsy increased over the study 
period (p<0.001), while NS decreased from the second decade (1992 - 
2001) to the third decade (2002 - 2011) (p<0.001). NS as an indication 
for biopsy declined with increasing age, in contrast to AKI, which 
became a more frequent indication for biopsy with increasing age.
The most frequent histological findings for patients biopsied for 
NS were FSGS (19.8%), MGN (19.2%), LN (12.3%), MCD (11.0%), 
MPGN (10.6%) and HIV-associated nephropathy (HIVAN) (4.4%). 
Among these patients, FSGS occurred most frequently in those aged 
<20 years, while MGN was most frequent in patients aged >20 years.
The most frequent findings in HIV-positive individuals with 
nephrotic-range proteinuria were HIVAN (27.3%, n=39), FSGS 
(17.5%, n=25) and MGN (15.4%, n=22), compared with FSGS 
(19.5%, n=89), MGN (19.5%, n=89) and LN (17.1%, n=78) in HIV-
negative individuals.
Of patients biopsied for AKI, 16.9% had HIVAN, 15.0% ATN, 9.0% 
LN, 8.5% MHN, 8.5% IN and 8.2% FSGS, while the most frequent 
findings in patients biopsied for AUAs were LN (80.0%), HIV 
immune complex disease (HIV-ICD) (4.0%), normal kidney (3.3%), 
IN (2.0%) and FSGS (2.0%).
SGNs (including ID, SD, MD and VD) were the most frequent 
histological findings, being present in a total of 911 biopsies (49.3%), 
while PGNs were diagnosed in 734 (39.7%) of biopsies, TID in 136 
(7.4%) and miscellaneous diseases/other in 67 (3.6%).
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PGNs decreased significantly over time (p<0.001), while SGNs 
increased, PGNs accounting for 37.7% (n=215) of biopsies between 
1982 and 1991, 47.5% (n=179) between 1992 and 2001, and 57.4% 
(n=517) between 2002 and 2011 (p<0.001). The proportions of PGN 
during the three 10-year periods and changes over time are set out 
in Table 1.
FSGS was the most frequent PGN across all age groups, occurring 
in the same proportion (40.0%) as MGN in patients aged >60 years. 
No statistically significant associations between PGNs and the 
different age groups were found.
Glomerular diseases secondary to IDs followed by SDs were 
the most frequent causes of SGNs. Of the SGNs, the proportion of 
ID increased significantly over time (p<0.001) and VD decreased 
significantly from the first to the second 10-year period (p=0.001), 
while the proportion of SD (with LN as sole contributor) increased 
significantly over the same period (p<0.001). DN accounted for 
6.6% of SGNs and was present in 3.2% (n=60) of all biopsies. The 
proportions of the SGN groups are shown in Table 2, and the eight 
most frequently occurring SGNs and their changes over time in 
Table 3.
LN occurred more frequently in females than in males (89.4% 
v. 10.6%; p<0.001), and more frequently in 20 - 39-year-olds than 
in individuals aged ≥40 years (p<0.001). No statistically significant 
association between ethnicity and LN was found. The most frequent 
clinical indications for renal biopsy in patients with LN were AUAs 
(42.6%), NS (38.3%) and AKI (11.7%). Class 5 LN alone (25.9%) was 
the most frequent International Society of Nephrology (ISN)/Renal 
Pathology Society (RPS) LN class found, and was present in a total 
of 53.2% (n=150) of LN biopsies. Class 4 alone accounted for 18.8% 
(n=53) of LN biopsies and class 3 alone for 16.7% (n=47).
The majority of ID-related biopsies were related to HIV, with 
a dominant diagnosis of HIVAN (32.7%). The major histological 
findings in HIV-positive individuals are shown in Fig. 1. Of the HIV-
positive individuals, 265 (72.8%) had CD4+ counts recorded (median 
CD4+ count 195 cells/µL, range 1 - 1 605). CD4+ counts ≤50 cells/µL 
were associated with HIVAN as a diagnosis (p<0.001). The median 
Table 1. Proportions of primary glomerular diseases and changes over time
 
1 Jan 1982 - 31 Dec 1991 
(N=274), n (%)
1 Jan 1992 - 31 Dec 2001 
(N=167), n (%)
1 Jan 2002 - 31 Dec 2011 
(N=293), n (%)
1 Jan 1982 - 31 Dec 2011 
(N=734), n (%) p-value
CresGN 4 (1.5) 3 (1.8) 2 (0.7) 9 (1.2) -
FSGS 69 (25.2) 40 (24.0) 108 (36.9) 217 (29.6) 0.002
IgAN 12(4.4) 5 (3.0) 9 (3.1) 26 (3.5) 0.638
IgMN 1 (0.4) 1 (0.6) 0 2 (0.3) -
MCD 53 (19.3) 15 (9.0) 37 (12.6) 105 (14.3) 0.006
MGN 67 (24.5) 50 (29.9) 72 (24.6) 189 (25.7) 0.370
MPGN 42 (15.3) 40 (24.0) 51 (17.4) 133 (18.1) 0.068
MsPGN 21 (7.7) 13 (7.8) 14 (4.8) 48 (6.5) 0.290
ProlifGN 5 (1.8) 0 0 5 (0.7) -
CresGN = crescentic glomerulonephritis; FSGS = focal segmental glomerulosclerosis; IgAN = immunoglobulin A nephropathy; IgMN = immunoglobulin M nephropathy;  
MCD = minimal-change disease; MGN = membranous glomerulopathy/glomerulonephritis; MPGN = membranoproliferative glomerulonephritis; MsPGN = mesangioproliferative 
glomerulonephritis; ProlifGN = proliferative glomerulonephritis; - = owing to the small number represented in the sample, a χ2 and associated p-value could not be calculated.
Table 2. Proportions of secondary glomerular disease groups
1 Jan 1982 - 31 Dec 1991 
(N=215), n (%)
1 Jan 1992 - 31 Dec 2001 
(N=179), n (%)
1 Jan 2002 - 31 Dec 2011 
(N=517), n (%)
1 Jan 1982 - 31 Dec 2011 
(N=911), n (%)
ID 50 (23.3) 43 (24.0) 206 (39.8) 299 (32.8)
MD 26 (12.1) 20 (11.2) 47 (9.1) 93 (10.2)
SD 46 (21.4) 87 (48.6) 149 (28.8) 282 (31.0)
VD 93 (43.3) 29 (16.2) 115 (22.2) 237 (26.0)
ID = infectious diseases; MD = metabolic and deposit diseases; SD = systemic diseases; VD = vascular diseases.
Table 3. Most frequent secondary glomerular diseases for each 10-year period and the total study period
 
1 Jan 1982 - 31 Dec 1991 
(N=215), n (%)
1 Jan 1992 - 31 Dec 2001 
(N=179), n (%)
1 Jan 2002 - 31 Dec 2011 
(N=517), n (%)
1 Jan 1982 - 31 Dec 2011 
(N=911), n (%) p-value
AMY 16 (7.4) 4 (2.2) 8 (1.5) 28 (3.1) <0.001
BHN 48 (22.3) 4 (2.2) 36 (7.0) 88 (9.7) <0.001
DN 10 (4.7) 16 (8.9) 34 (6.6) 60 (6.6) 0.232
HIVAN 1 (0.5) 12 (6.7) 108 (20.9) 121 (13.3) <0.001
HIV-ICD 0 0 43 (8.3) 43 (4.7) <0.001
LN 46 (21.4) 87 (48.6) 149 (28.8) 282 (31.0) <0.001
MHN 41 (19.1) 13 (7.3) 60 (11.6) 114 (12.5) 0.001
PIGN 36 (16.7) 24 (13.4) 23 (4.4) 83 (9.1) <0.001
AMY = amyloidosis; BHN = benign hypertensive nephroangiosclerosis; DN = diabetic nephropathy; HIVAN = HIV-associated nephropathy; HIV-ICD = HIV immune complex disease;  
LN = lupus nephritis; MHN = malignant hypertensive nephroangiosclerosis; PIGN = post-infectious glomerulonephritis.
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creatinine level for HIV-positive patients was 316 µmol/L and the 
median protein-creatinine ratio (PCR) 0.61 g/mmol, which is in the 
nephrotic range of proteinuria. The median CD4+ count, creatinine 
level and PCR for different histopathological diagnoses in HIV-
positive patients are shown in Table 4.
In patients who were co-infected with HBV and HIV, the most 
prevalent findings were HIVAN (25.0%, n=8) followed by FSGS 
and MGN (15.6% (n=5) each). In patients with HCV and HIV 
co-infection, the most prevalent findings were HIVAN (29.4%, n=5) 
and HIV-ICD (17.6%, n=3), followed by FSGS and MCD (11.8% 
(n=2) each).
PIGN was present in 83 patients (4.5%). The frequency of PIGN 
as a cause of SGN decreased significantly during the study period 
(p<0.001). Most patients with PIGN were of black ethnicity (96.4%, 
n=80), while 65.1% of patients with PIGN were aged <40 years.
Discussion
Studies from SA relating to histopathological findings in renal disease 
are from different geographical areas, and ethnic distributions in the 
study populations vary. We reviewed a sample in Gauteng Province 
that largely consisted of patients of black ethnicity (96.4%), while 
other studies were of predominantly mixed-race patients (53.7%) in 
Cape Town, Western Cape Province,[13] and 57.2% black and 35.9% 
white patients in Bloemfontein, Free State Province.[15] Our study 
adds significantly to the knowledge regarding the patterns of renal 
disease in SA and sub-Saharan Africa as a whole, where the majority 
of patients are of black ethnicity.
As can be seen in Table 5, we found indications for biopsy 
similar to those in published studies from Africa,[13,15-19] the Middle 
East,[20,21] Asia,[22-26] South America[12,27] and parts of Europe,[28,29] 
with the most frequent indication for biopsy being nephrotic-range 
proteinuria (47.7%). However, studies in Belgium,[11] Finland[30] and 
Italy[31] reported AUAs as the most frequent indication for biopsy, 
possibly because their well-resourced healthcare systems enable early 
detection of asymptomatic disease. With that said, after AKI (19.8%) 
as the second most prevalent indication for biopsy, AUAs were in fact 
the third most prevalent indication in the present study, accounting 
for 8.1% of biopsies. This probably reflects the active screening for 
renal disease in LN patients at our facility, as most patients biopsied 
for AUA had LN (80.0%). CKD was the most frequent indication 
in France[32] and chronic nephritic syndrome in Japan,[33] probably 
owing to the high prevalence of IgAN in that part of the world.
The three most frequent histological findings in patients with NS 
in our study were FSGS (19.8%), MGN (19.2%) and LN (12.3%). 
However, when evaluating nephrotic-range proteinuria and NS in 
294 black patients, Okpechi et al.[34] in Cape Town identified the 
most frequent causes of NS as HIVAN (25.2%), MPGN (7.8%) and 
LN (7.8%), while Seedat[35] in Durban, SA, reported MPGN to be 
the most frequent cause of NS in black patients (47.0%), followed by 
MGN (25.0%).
We found that SGNs (49.3%) occurred more frequently than PGNs 
(39.7%). Together with the findings of Okpechi et al.[13] in Cape Town 
and Mesquita et al.[11] in Belgium, this contrasts with the majority of 
studies, which report PGNs as occurring more frequently.
The most frequent PGNs in the present study were FSGS (29.6%), 
MGN (25.7%) and MPGN (18.1%), which is in keeping with other 
studies from Africa[15,16,18,19,36] that report FSGS as the most frequent 
PGN. The high frequency of FSGS in our study sample may be 
explained by a possible genetic predisposition in the predominantly 
black patient population, similar to that shown in African Americans, 
where the presence of a single APOL1 risk allele (G1 or G2) is associated 
with a 17-fold higher odds for FSGS and a 29-fold higher odds for 
HIVAN.[37] Preliminary data from SA show that individuals carrying 
any combination of two APOL1 risk alleles have 89-fold higher odds of 
developing HIVAN and 6.3 higher odds for primary FSGS; population 
allele frequencies were 7.3% for G1 and 11.1% for G2.[38] Further 
research is required to adequately explore this hypothesis and to clarify 
the reasons for the higher frequency of FSGS.
IgAN accounted for only 3.5% of PGN in the present study, while 
IgAN is reported as the most frequent PGN in most of Europe,[29-32] 
                    
ATN 4.7%
BHN 3.0%
 DN 4.4% 
FSGS 11.3%
HIVAN 32.7%
HIV-ICD 11.8%
MGN 7.7%
IN 3.8%
LN 4.4%
MCD 3.3%
MPGN 
2.7%
MHN 
2.5%
Fig. 1. Histopathological findings in HIV-positive individuals. (ATN = acute 
tubular necrosis; BHN = benign hypertensive nephroangiosclerosis; DN = 
diabetic nephropathy; FSGS = focal segmental glomerulosclerosis; HIVAN = 
HIV-associated nephropathy; HIV-ICD = HIV immune complex disease; 
MGN = membranous glomerulopathy; IN = interstitial nephritis; LN = lupus 
nephritis; MCD = minimal-change disease; MPGN = membranoproliferative 
glomerulonephritis; MHN = malignant hypertensive nephroangiosclerosis.)
Table 4. CD4+ counts, serum creatinine levels and PCR for various histopathological diagnoses in HIV-positive patients
Histopathological diagnosis
CD4+ count (cells/µL), 
median (IQR)
Creatinine (µmol/L), 
median (IQR)
PCR (g/mmol),  
median (IQR)
HIVAN 92 (28 - 196) 539 (279 - 799) 0.92 (0.37 - 1.44)
HIV-ICD 198 (85 - 297) 141 (76 - 435) 0.31 (0.06 - 0.70)
FSGS 434 (174 - 566) 104 (80 - 331) 0.83 (0.40 - 1.38)
MGN 360 (197 - 491) 89 (74 - 220) 0.78 (0.46 - 0.99)
MCD 165 (77 - 226) 119 (76 - 175) 0.83 (0.26 - 1.51)
MPGN 380 (316 - 435) 207 (76 - 333) 0.99 (0.28 - 1.20)
PCR = protein-creatinine ratio; IQR = interquartile range; HIVAN = HIV-associated nephropathy; HIV-ICD = HIV immune complex disease; FSGS = focal segmental glomerulosclerosis;  
MGN = membranous glomerulopathy/glomerulonephritis; MCD = minimal-change disease; MPGN = membranoproliferative glomerulonephritis.
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parts of Asia,[25,33,39] the USA (white Americans)[40] and Australia.[41] It 
is possible that IgAN may be under-represented in our study because 
of the ethnic distribution of the study sample and because patients 
with isolated haematuria are not often subjected to renal biopsy.
The present study found, as in most other parts of the world 
including SA,[12,13,15,17,19-24,26-29,36,39] that LN (31.0%) was the most 
frequent SGN, followed in our study by HIVAN (13.3%) and MHN 
(12.5%). The most frequent ISN/RPS histological subtypes of LN 
in our study, class V (25.9%) followed by class IV (18.8%), differ 
from Okpechi et al.’s[42] finding that subtypes class III and IV (20.7% 
each) occurred most frequently in their Cape Town sample. The 
frequencies of class I and class II LN may be under-represented 
in general, as most patients with these two classes of LN are not 
routinely biopsied owing to inactive urine sediment, proteinuria 
<1 g/d and normal kidney function.[43]
The first patient in the present study to be reported as HIV-
positive was a patient with HIVAN in 1989, 5 years prior to the first 
published case of HIVAN in SA, reported by Bates et al.[44] in 1994. 
The proportion of HIV-positive patients in our study increased over 
the study period (p<0.001), and with 37.8% HIV-positive biopsies 
between 1 January 2002 and 31 December 2011, the prevalence was 
higher than the highest reported antenatal HIV seroprevalence in 
Gauteng for the same period, which was 33.1% in 2004.[45]
Similar to our study, histological patterns in HIV-positive 
individuals from other parts of SA as well as from the USA indicate 
HIVAN to be the most frequent histopathological finding. The most 
frequent findings in HIV-positive individuals in the present study 
were HIVAN (32.7%), HIV-ICD (11.8%) and FSGS (11.3%). HIVAN 
accounted for 55.3% of biopsies at Groote Schuur Hospital in Cape 
Town[46] and 83% in Durban,[47] followed by ATN (8.0%) and ESKD 
(7.2%) in Cape Town and IN (10.0%) and MPGN (7.0%) in Durban. 
Berliner et al.[48] in Baltimore, USA, reported HIVAN (35%), non-
collapsing FSGS (22%) and acute interstitial nephritis (7.9%) as 
their most frequent findings. The differences in HIVAN prevalence 
between the SA studies are not surprising in themselves – as pointed 
out by Koech et al.,[49] studies show great variability in the prevalence 
of HIVAN in HIV-positive populations. This variability is poorly 
understood but could be influenced by various factors, including, 
Table 5. Comparative summary of histopathology findings from similar studies
Country Year Author
Most frequent 
indication (%)
Most frequent 
group (%)
Most frequent 
PGN (%)
Most frequent 
SGN (%)
Africa
SA, CHBAH (present study) Vermeulen et al. NS (47.7) SGN (49.3) FSGS (29.6) LN (31)
SA, CPT 2011 Okpechi et al.[13] NS (52.5) SGN (49.0) MPGN (20.4) LN (39)
SA, Bloemfontein 2010 Jansen van Rensburg et al.[15] NS - FSGS -
Egypt 2000 Barsoum and Francis[16] NS (31.9) - FSGS (22.6) -
Morocco 2012 Aatif et al.[17] NS (60.3) PGN (52) MCD (26) LN (45)
Oman 2013 Dawood et al.[36] - SGN FSGS LN (36.1)
Senegal 2003 Abdou et al.[18] NS (67) PGN (69.5) FSGS (47) LN (55.5)
Sudan 2013 Nadium et al.[19] NS (46.5) PGN (85.5) FSGS (29.6) -
Middle East       
Iran 2010 Ossareh et al.[20] NS (57.4) PGN (74.8) MGN (35.8) LN (64.3)
Jordan 2008 Wahbeh et al.[21] NS (51.6) PGN (59.4) FSGS LN
Europe       
Belgium 2011 Mesquita et al.[11] AUA (53.5) SGN (39.9) FSGS (30.3) IMGN (32.3)
Finland 2008 Wirta et al.[30] AUA (38.7) PGN IgAN (34.9) -
France 2004 Simon et al.[32] CKD (36) PGN IgAN (73.4) -
Italy 2004 Gesualdo et al.[31] AUA PGN (64.3) IgAN (34.5) IMGN
Serbia 2009 Naumovic et al.[28] NS (53.6) PGN (64.2) MsPGN, non-
IgA (25.1)
LN (75.6)
Spain 2002 Rivera et al.[29] NS (35.2) PGN IgAN (17.2) LN
Asia       
China 2012 Hsiao et al.[22] NS (52) PGN (55) MGN (31.7) LN (53.2)
East India 2013 Golay et al.[23] NS (61.6) PGN (79.13) FSGS LN (73.38)
South India 2011 Das et al.[24] NS (49) PGN (69.1) MCD (21.8) LN (80.1)
Japan 2011 Sugiyama et al.[33] CNS (48.2) PGN IgAN (27.6) DN
Korea 2009 Chang et al.[39] - PGN IgAN (28.3) LN (74)
Northern China 2009 Zhou et al.[25] NS PGN (63.3) IgAN (54.5 ) -
Pakistan 2011 Mubarak et al.[26] NS (49.9) PGN (73) FSGS (29) LN (44.1)
Americas       
Brazil 2010 Polito et al.[12] NS (39) PGN (51) FSGS (24.6) LN (45.5)
Colombia 2009 Arias et al.[27] NS PGN (76.2) FSGS (37.7) LN (90.9)
USA, Minnesota 2006 Swaminathan et al.[40] - - IgAN (22) -
Australia 2001 Briganti et al.[41] - - IgAN (34.1) -
PGN = primary glomerular disease; SGN = secondary glomerular disease; SA = South Africa: CHBAH = Chris Hani Baragwanath Academic Hospital; CPT = Cape Town; NS = nephrotic 
syndrome; FSGS = focal segmental glomerulosclerosis; LN = lupus nephritis; MPGN = membranoproliferative glomerulonephritis; MCD = minimal-change disease; MGN = membranous 
glomerulopathy/glomerulonephritis; AUA = asymptomatic urine abnormality; IMGN = immune-mediated glomerulonephritis; IgAN = immunoglobulin A nephropathy; CKD = chronic kidney 
disease; MsPGN = mesangioproliferative glomerulonephritis; CNS = chronic nephritic syndrome; - = not reported.
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as pointed out by Wearne et al.,[50] differing approaches to the 
classification of HIVAN between studies, differences in duration of 
HIV infection, or genetic differences between populations. Regardless 
of the apparent variability, HIVAN does appear to be the most 
prevalent finding in HIV-positive biopsies and has been increasing.
The statistically significant increase in SGNs (p<0.001) and 
decrease in PGNs (p<0.001) in the present study can probably be 
explained by the increase in ID (p<0.001) during the study period, 
which in turn is likely to be linked to the increased prevalence of 
HIV-related diseases during the last decade between 2002 and 2011.
Non-SA studies reporting on differences in the frequency of age-
related PGN report the most frequent PGNs in young adults to be 
either IgAN or FSGS, and in the elderly, MGN.[3] The present study 
found FSGS to be the most frequent PGN across all age groups except 
for patients aged 20 - 39 years and those aged ≥60, among whom 
FSGS and MGN occurred at the same frequency. Similar to the 
present study, MGN was also reported to be the most frequent PGN 
in the elderly in France,[31] Ireland,[51] Brazil[12] and Cape Town. [13] 
Okpechi et al.,[13] however, found MPGN to be the most frequent 
PGN in patients aged <60.
Study limitations
The retrospective nature of the present study leads to some 
limitations. Inconsistencies in the recording and reporting of data 
over the 30-year period as well as records that might have been 
misplaced make it possible that some biopsies or associated data were 
not included in the data set. However, every effort was made to locate 
all relevant records and data, including sourcing of archival patient 
records. Some renal diseases could be under-represented in the data 
because affected patients are not routinely biopsied; DN and isolated 
microscopic haematuria that may be due to IgAN are two such 
conditions. Contraindications to renal biopsy in patients who present 
with advanced renal failure may result in under-representation of 
the true frequency of various pathologies, including HIVAN and 
HIV-ICD. The data may also be skewed by the high referral rate for 
biopsies of systemic lupus erythematosus patients by the Division 
of Rheumatology at CHBAH. As some patients are likely to use the 
private health sector or simply prefer to make use of other hospitals, 
the sample of biopsies in this study may not fully represent the 
complete picture of renal disease for patients in the Soweto area. 
Generalisation from our results should be made cautiously.
Conclusions
Overall, the present study contributes to the literature on patterns 
of renal disease in SA as well as sub-Saharan Africa, and when 
compared with existing studies shows variation in patterns of renal 
disease seen in diverse ethnic populations, various geographical 
areas and differing socioeconomic groups worldwide. The apparent 
impact of HIV on renal disease epidemiology is noteworthy. Our 
study describes the patterns of renal disease in a predominantly black 
African population and may aid as a guide to possible pathological 
diagnosis in black patients with contraindications to or no access 
to renal biopsy. The study points to the potential value of research 
regarding genetic profiling of the SA renal disease population 
to determine the actual prevalence of the APOL1 gene. Further 
prospective research on patterns of renal disease and studies linking 
outcomes in this area are also recommended.
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